Press Releases

Please click here if you wish to receive an e-mail notification regarding Alector press releases.

Jun 10, 2024

Alector to Host Virtual Research and Development Event Highlighting Alector Brain Carrier Blood-Brain Barrier Technology Platform

Jun 03, 2024

Alector to Participate in the Goldman Sachs 45th Annual Global Healthcare Conference

May 09, 2024

Alector to Participate in Upcoming Healthcare Conferences

May 08, 2024

Alector Reports First Quarter 2024 Financial Results and Provides Business Update

Feb 28, 2024

Alector to Participate in Upcoming Healthcare Conferences

Feb 27, 2024

Alector Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business Update

Feb 20, 2024

Alector to Host Fourth Quarter and Full-Year 2023 Earnings Call

Feb 08, 2024

Alector Announces First Patient Dosed in PROGRESS-AD Phase 2 Clinical Trial of AL101/GSK4527226 in Patients with Early Alzheimer’s Disease

Feb 07, 2024

FDA Grants Latozinemab Breakthrough Therapy Designation for Frontotemporal Dementia Due to a Progranulin Gene Mutation (FTD-GRN)

Jan 19, 2024

Alector Announces Closing of Public Offering
Displaying 11 - 20 of 22

Close

Are you sure you want to leave?

You are about to leave the Alector site. Please note our privacy policy won’t apply to these third-party sites.

Continue
Cancel